A Phase III Prospective Randomised Clinical Trial of Accelerated Radiotherapy (ART) for Stage III and IV Squamous Carcinoma of the Upper Aerodigestive Tract

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Related Post

17 September, 2026

Meet the TROG Quality Assurance team

TROG UPDATES: 17 September 2026 Our Quality Assurance team

17 September, 2026

TROG trial of new lung cancer radiation therapy approach opens

LATEST NEWS: 17 September 2026 The first Australian site